• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用硼簇(特别是碳硼烷)功能化的树枝状结构及其生物学特性。

Dendritic Structures Functionalized with Boron Clusters, in Particular Carboranes, and Their Biological Properties.

作者信息

Caminade Anne-Marie, Milewski Max, Hey-Hawkins Evamarie

机构信息

Laboratoire de Chimie de Coordination (LCC-CNRS) 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France.

LCC-CNRS, Université de Toulouse, CNRS, 31077 Toulouse, France.

出版信息

Pharmaceutics. 2023 Aug 10;15(8):2117. doi: 10.3390/pharmaceutics15082117.

DOI:10.3390/pharmaceutics15082117
PMID:37631334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10459656/
Abstract

The presence of a large number of boron atoms in boron clusters make them attractive tools for the treatment of cancer using boron neutron capture therapy (BNCT). Since the quantity of boron atoms present in the target cell directly affects the effectiveness of BNCT, the idea of gathering a high number of boron atoms in a single entity has emerged many years ago. In this perspective, using hyper-branched macromolecules such as dendrimers appears as an interesting solution. In this review, we will first present the synthesis of diverse dendritic entities (dendrimers, dendrons, and Janus dendrimers) that incorporate boron clusters, in particular carboranes, anywhere in their structure. Four parts of this review present the synthesis of dendrimers having boron clusters on the surface, or inside their structure, of dendrons and of Janus dendrimers, bearing boron clusters. Practically all these boronated dendritic structures were synthesized with the objective to study their biological properties, but in fact only a few of them have been tested against cancerous cells, and even a smaller number was tested in BNCT experiments. The biological experiments are discussed in the fifth part of this review. A good efficiency is generally observed with the boronated dendrimers, even in animal models, with an increase in their mean survival time (MST).

摘要

硼簇中大量硼原子的存在使其成为使用硼中子俘获疗法(BNCT)治疗癌症的有吸引力的工具。由于靶细胞中硼原子的数量直接影响BNCT的有效性,多年前就出现了在单个实体中聚集大量硼原子的想法。从这个角度来看,使用超支化大分子如树枝状大分子似乎是一个有趣的解决方案。在这篇综述中,我们将首先介绍各种包含硼簇(特别是碳硼烷)的树枝状实体(树枝状大分子、树枝状单体和Janus树枝状大分子)的合成,这些硼簇位于其结构的任何位置。本综述的四个部分分别介绍了表面带有硼簇、结构内部带有硼簇的树枝状大分子、带有硼簇的树枝状单体以及Janus树枝状大分子的合成。实际上,所有这些含硼树枝状结构的合成目的都是研究其生物学性质,但事实上,其中只有少数针对癌细胞进行了测试,在BNCT实验中测试的数量更少。生物学实验将在本综述的第五部分进行讨论。即使在动物模型中,含硼树枝状大分子通常也表现出良好的效果,其平均生存时间(MST)有所增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/292ae3d9e03a/pharmaceutics-15-02117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d189be114980/pharmaceutics-15-02117-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/31d97144e4d7/pharmaceutics-15-02117-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/f23c72a9afd9/pharmaceutics-15-02117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/f57b9fcee01a/pharmaceutics-15-02117-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/4fe88e0da184/pharmaceutics-15-02117-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d835afc51e9e/pharmaceutics-15-02117-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/caecc1460d0c/pharmaceutics-15-02117-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8a06a1c09413/pharmaceutics-15-02117-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/de3f3ee8e9c1/pharmaceutics-15-02117-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/89adf0d94f88/pharmaceutics-15-02117-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/a84dad2d81ad/pharmaceutics-15-02117-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8a54e330d72e/pharmaceutics-15-02117-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/da73048b252f/pharmaceutics-15-02117-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/989d753a8820/pharmaceutics-15-02117-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/2fb98fd0972f/pharmaceutics-15-02117-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/29253f42e673/pharmaceutics-15-02117-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/94630b315166/pharmaceutics-15-02117-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/7fa3ef9d8c7f/pharmaceutics-15-02117-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/1ecfd73c1892/pharmaceutics-15-02117-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/2edc424c6672/pharmaceutics-15-02117-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8697961a57a8/pharmaceutics-15-02117-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/0d6d32bc6464/pharmaceutics-15-02117-sch021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/dec01d11665e/pharmaceutics-15-02117-sch022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/c545e2036658/pharmaceutics-15-02117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d9a09f45e08e/pharmaceutics-15-02117-sch023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/378f9f44734b/pharmaceutics-15-02117-sch024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/809b66557f37/pharmaceutics-15-02117-sch025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/73993cb55968/pharmaceutics-15-02117-sch026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/bc086ff8e1cd/pharmaceutics-15-02117-sch027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8c459607bc0a/pharmaceutics-15-02117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/292ae3d9e03a/pharmaceutics-15-02117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d189be114980/pharmaceutics-15-02117-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/31d97144e4d7/pharmaceutics-15-02117-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/f23c72a9afd9/pharmaceutics-15-02117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/f57b9fcee01a/pharmaceutics-15-02117-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/4fe88e0da184/pharmaceutics-15-02117-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d835afc51e9e/pharmaceutics-15-02117-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/caecc1460d0c/pharmaceutics-15-02117-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8a06a1c09413/pharmaceutics-15-02117-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/de3f3ee8e9c1/pharmaceutics-15-02117-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/89adf0d94f88/pharmaceutics-15-02117-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/a84dad2d81ad/pharmaceutics-15-02117-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8a54e330d72e/pharmaceutics-15-02117-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/da73048b252f/pharmaceutics-15-02117-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/989d753a8820/pharmaceutics-15-02117-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/2fb98fd0972f/pharmaceutics-15-02117-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/29253f42e673/pharmaceutics-15-02117-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/94630b315166/pharmaceutics-15-02117-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/7fa3ef9d8c7f/pharmaceutics-15-02117-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/1ecfd73c1892/pharmaceutics-15-02117-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/2edc424c6672/pharmaceutics-15-02117-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8697961a57a8/pharmaceutics-15-02117-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/0d6d32bc6464/pharmaceutics-15-02117-sch021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/dec01d11665e/pharmaceutics-15-02117-sch022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/c545e2036658/pharmaceutics-15-02117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/d9a09f45e08e/pharmaceutics-15-02117-sch023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/378f9f44734b/pharmaceutics-15-02117-sch024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/809b66557f37/pharmaceutics-15-02117-sch025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/73993cb55968/pharmaceutics-15-02117-sch026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/bc086ff8e1cd/pharmaceutics-15-02117-sch027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/8c459607bc0a/pharmaceutics-15-02117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e70/10459656/292ae3d9e03a/pharmaceutics-15-02117-g004.jpg

相似文献

1
Dendritic Structures Functionalized with Boron Clusters, in Particular Carboranes, and Their Biological Properties.用硼簇(特别是碳硼烷)功能化的树枝状结构及其生物学特性。
Pharmaceutics. 2023 Aug 10;15(8):2117. doi: 10.3390/pharmaceutics15082117.
2
Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.叶酸受体靶向硼化聚酰胺-胺树枝状大分子作为中子俘获治疗潜在药物的合成与生物学评价
Bioconjug Chem. 2003 Jan-Feb;14(1):158-67. doi: 10.1021/bc025586o.
3
In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.用于硼中子俘获疗法(BNCT)的碳硼烷的体内应用:结构、制剂及检测分析方法
Cancers (Basel). 2023 Oct 11;15(20):4944. doi: 10.3390/cancers15204944.
4
PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).载药脂质体包裹的 nido-卡硼烷在硼中子俘获治疗(BNCT)中显示出显著的肿瘤抑制作用。
Biochem Biophys Res Commun. 2020 Feb 12;522(3):669-675. doi: 10.1016/j.bbrc.2019.11.144. Epub 2019 Nov 28.
5
Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry.含硼烷的羟肟酸 MMP 配体用于硼中子俘获治疗(BNCT)治疗肿瘤:无需肿瘤细胞进入即可发挥疗效。
Int J Mol Sci. 2023 Apr 9;24(8):6973. doi: 10.3390/ijms24086973.
6
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.含硼大分子和纳米载体作为中子俘获治疗的递送剂
Anticancer Agents Med Chem. 2006 Mar;6(2):167-84. doi: 10.2174/187152006776119153.
7
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.硼化星爆树枝状大分子-单克隆抗体免疫缀合物:作为中子俘获治疗潜在递送系统的评估
Bioconjug Chem. 1994 Jan-Feb;5(1):58-66. doi: 10.1021/bc00025a008.
8
Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).用于硼中子俘获疗法(BNCT)的含硼胆固醇模拟物的受体靶向脂质体递送。
Bioconjug Chem. 2006 Sep-Oct;17(5):1141-50. doi: 10.1021/bc060075d.
9
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.下一代硼中子俘获治疗(BNCT)癌症治疗药物。
Med Res Rev. 2023 Sep;43(5):1809-1830. doi: 10.1002/med.21964. Epub 2023 Apr 27.
10
Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.硼中子俘获治疗中功能化碳硼烷的金纳米粒子的合理设计。
Int J Pharm. 2013 Dec 31;458(2):340-6. doi: 10.1016/j.ijpharm.2013.10.008. Epub 2013 Oct 16.

引用本文的文献

1
Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday, Recognizing His Outstanding Achievements in Advancing the Field of Dendrimers.树枝状大分子:为纪念唐纳德·A·托马利亚教授85岁生日而推出的专题,以表彰他在推动树枝状大分子领域发展方面的杰出成就。
Pharmaceutics. 2024 Dec 17;16(12):1608. doi: 10.3390/pharmaceutics16121608.
2
Dendrimers, Dendrons, and the Dendritic State: Reflection on the Last Decade with Expected New Roles in Pharma, Medicine, and the Life Sciences.树枝状大分子、树枝状单体与树枝状状态:对过去十年的反思以及在制药、医学和生命科学领域的新角色展望
Pharmaceutics. 2024 Nov 28;16(12):1530. doi: 10.3390/pharmaceutics16121530.

本文引用的文献

1
Dendrimers, an Emerging Opportunity in Personalized Medicine?树枝状大分子,个性化医疗的新机遇?
J Pers Med. 2022 Aug 19;12(8):1334. doi: 10.3390/jpm12081334.
2
Preparation of dendritic carboranyl glycoconjugates as potential anticancer therapeutics.作为潜在抗癌治疗药物的树枝状碳硼烷糖缀合物的制备。
RSC Adv. 2020 Sep 18;10(57):34764-34774. doi: 10.1039/d0ra07264h. eCollection 2020 Sep 16.
3
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.
脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.
4
Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system.用于临床硼中子俘获治疗的治疗计划系统的评估,并针对独立的蒙特卡罗剂量计算系统进行验证。
Radiat Oncol. 2021 Dec 24;16(1):243. doi: 10.1186/s13014-021-01968-2.
5
Periphery Decorated and Core Initiated Neutral and Polyanionic Borane Large Molecules: Forthcoming and Promising Properties for Medicinal Applications.外围修饰且核心引发的中性和聚阴离子硼烷大分子:医学应用中即将具备且颇具前景的特性
Curr Med Chem. 2019;26(26):5036-5076. doi: 10.2174/0929867326666190603123838.
6
Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy.树状高分子作为癌症放化疗中创新型放射性药物
Biomacromolecules. 2016 Oct 10;17(10):3103-3114. doi: 10.1021/acs.biomac.6b00929. Epub 2016 Sep 20.
7
Icosahedral boron clusters: a perfect tool for the enhancement of polymer features.二十面体硼簇:增强聚合物性能的完美工具。
Chem Soc Rev. 2016 Oct 7;45(19):5147-73. doi: 10.1039/c6cs00159a. Epub 2016 May 18.
8
Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.硼中子俘获疗法的肿瘤靶向策略进展
Pharm Res. 2015 Sep;32(9):2824-36. doi: 10.1007/s11095-015-1718-y. Epub 2015 Jun 2.
9
High-boron-content porphyrin-cored aryl ether dendrimers: controlled synthesis, characterization, and photophysical properties.高硼含量卟啉核芳基醚树枝状大分子:可控合成、表征及光物理性质
Inorg Chem. 2015 May 18;54(10):5021-31. doi: 10.1021/acs.inorgchem.5b00618. Epub 2015 Apr 29.
10
Tumor targeting, trifunctional dendritic wedge.肿瘤靶向性三功能树突状楔形体
Bioconjug Chem. 2015 Jan 21;26(1):78-89. doi: 10.1021/bc500436b. Epub 2014 Nov 12.